# Systematic Reviews - Domain Knowledge

## Overview
A systematic review is a rigorous, transparent, and reproducible method for identifying, evaluating, and synthesizing all available research evidence on a specific question. It follows a predefined protocol to minimize bias and ensure comprehensive coverage.

## PRISMA 2020 Guidelines

### The 27-Item Checklist

**Title (1)**
- Identify the report as a systematic review

**Abstract (2)**
- Structured summary: background, objectives, methods, results, conclusions, registration

**Introduction**
- Rationale (3): Describe the rationale in context of existing knowledge
- Objectives (4): Provide explicit statement of questions (PICO/SPIDER)

**Methods**
- Eligibility criteria (5): Specify inclusion/exclusion with rationale
- Information sources (6): Databases, registers, websites, dates searched
- Search strategy (7): Full search strategy for at least one database
- Selection process (8): How studies were selected (screening stages, reviewers)
- Data collection (9): Methods for extracting data, verification process
- Data items (10a): All variables collected, assumptions made
- Study risk of bias (10b): Tools used to assess bias
- Effect measures (11): Specify for each outcome (RR, OR, MD, SMD)
- Synthesis methods (12): Methods for combining results, heterogeneity assessment
- Reporting bias (13): Methods to assess publication bias (funnel plots, Egger's test)
- Certainty assessment (14): Methods for assessing certainty (GRADE)

**Results**
- Study selection (15): Results with reasons for exclusions (PRISMA flow diagram)
- Study characteristics (16): Cite each study, present characteristics
- Risk of bias (17): Present assessments for each study
- Results of syntheses (18): For each synthesis, present summary statistics, forest plots
- Reporting biases (19): Present assessments of publication bias
- Certainty of evidence (20): Present certainty ratings (GRADE)

**Discussion**
- Discussion (21a): Interpret results in context of other evidence
- Limitations (21b): Discuss limitations at study and review level
- Implications (22): Implications for practice, policy, future research

**Other Information**
- Registration (23): Registration number and name of registry
- Protocol (24): Where protocol can be accessed
- Support (25): Sources of financial/non-financial support
- Competing interests (26): Declare conflicts of interest
- Availability of data (27): State which data are publicly available

## Types of Systematic Reviews

### 1. Intervention Reviews
- **Purpose**: Assess effectiveness of interventions (treatments, programs, policies)
- **Framework**: PICO (Population, Intervention, Comparison, Outcome)
- **Analysis**: Often includes meta-analysis with pooled effect sizes
- **Example**: "Effectiveness of cognitive behavioral therapy for depression in adults"

### 2. Diagnostic Test Accuracy Reviews
- **Purpose**: Evaluate accuracy of diagnostic tests
- **Framework**: PICO adapted (Index test, Reference standard, Target condition)
- **Analysis**: Sensitivity, specificity, likelihood ratios, ROC curves
- **Tools**: QUADAS-2 for risk of bias assessment

### 3. Prognostic Reviews
- **Purpose**: Identify factors associated with future outcomes
- **Framework**: PICOTS (adds Time and Setting)
- **Analysis**: Hazard ratios, survival curves
- **Tools**: QUIPS for risk of bias assessment

### 4. Qualitative Evidence Synthesis
- **Purpose**: Synthesize qualitative research findings
- **Framework**: SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type)
- **Analysis**: Thematic synthesis, meta-ethnography, framework synthesis
- **Tools**: CASP for quality assessment

### 5. Mixed Methods Reviews
- **Purpose**: Integrate quantitative and qualitative evidence
- **Framework**: Combined PICO + SPIDER
- **Analysis**: Convergent, sequential, or embedded synthesis

## Key Methodological Concepts

### Search Strategy Development
1. **Concept Identification**: Break question into key concepts
2. **Synonym Generation**: List all possible terms (MeSH, keywords, variants)
3. **Boolean Logic**: Combine with AND/OR/NOT
4. **Field Tags**: Use [tiab], [MeSH], [All Fields] appropriately
5. **Filters**: Language, date, publication type, species
6. **Validation**: Should retrieve known relevant studies

**Example Search Structure**:
```
(depression OR depressive disorder OR major depressive disorder[MeSH])
AND
(cognitive behavioral therapy OR CBT OR cognitive therapy[MeSH])
AND
(randomized controlled trial[pt] OR randomized[tiab] OR placebo[tiab])
```

### Study Selection Process
1. **Deduplication**: Remove duplicate records across databases
2. **Title/Abstract Screening**: Two independent reviewers, conflicts resolved
3. **Full-Text Review**: Assess against eligibility criteria
4. **Exclusion Documentation**: Record reasons for exclusion
5. **PRISMA Flow Diagram**: Visual representation of selection process

### Data Extraction
**Essential Elements**:
- Study identifiers (authors, year, DOI/PMID)
- Study design (RCT, cohort, case-control, etc.)
- Population characteristics (n, age, sex, condition severity)
- Intervention/exposure details (dose, duration, delivery)
- Comparison/control details
- Outcomes (measures, timepoints, results)
- Risk of bias domains
- Funding sources

**Best Practices**:
- Use standardized extraction forms
- Pilot test on 3-5 studies
- Two independent extractors
- Contact authors for missing data
- Extract from most complete source (often supplementary materials)

### Risk of Bias Assessment

**For RCTs - Cochrane RoB 2 Tool**:
1. Randomization process
2. Deviations from intended interventions
3. Missing outcome data
4. Measurement of the outcome
5. Selection of the reported result

**Judgments**: Low risk / Some concerns / High risk

**For Observational Studies - ROBINS-I**:
1. Confounding
2. Selection of participants
3. Classification of interventions
4. Deviations from intended interventions
5. Missing data
6. Measurement of outcomes
7. Selection of reported results

### Certainty of Evidence - GRADE

**Four Levels**:
- **High**: Very confident in effect estimate
- **Moderate**: Moderately confident; true effect likely close to estimate
- **Low**: Limited confidence; true effect may differ substantially
- **Very Low**: Very little confidence; true effect likely substantially different

**Factors Decreasing Certainty**:
- Risk of bias (-1 or -2)
- Inconsistency/heterogeneity (-1 or -2)
- Indirectness (-1 or -2)
- Imprecision (-1 or -2)
- Publication bias (-1)

**Factors Increasing Certainty** (observational studies only):
- Large effect (+1 or +2)
- Dose-response gradient (+1)
- All plausible confounding would reduce effect (+1)

## Common Pitfalls to Avoid

### Search-Related
‚ùå **Single database search**: Always search ‚â•2 databases
‚ùå **No grey literature**: Include conference abstracts, dissertations, trial registries
‚ùå **Overly restrictive**: Avoid unnecessary language/date restrictions
‚ùå **No search validation**: Test if known studies are retrieved

### Selection-Related
‚ùå **Single reviewer**: Always use ‚â•2 independent reviewers
‚ùå **No conflict resolution**: Define process for disagreements
‚ùå **Post-hoc criteria changes**: Stick to protocol or document deviations

### Analysis-Related
‚ùå **Inappropriate pooling**: Don't meta-analyze if I¬≤ >75% without investigation
‚ùå **Ignoring heterogeneity**: Always assess and explain heterogeneity
‚ùå **Cherry-picking outcomes**: Report all pre-specified outcomes
‚ùå **No sensitivity analysis**: Test robustness of findings

### Reporting-Related
‚ùå **Incomplete PRISMA**: Must complete all 27 items
‚ùå **No protocol registration**: Register on PROSPERO before starting
‚ùå **Selective reporting**: Report all outcomes, even non-significant
‚ùå **No data availability**: Share extraction data when possible

## Registration and Protocol

### PROSPERO Registration
- **When**: Before starting data extraction (ideally before screening)
- **Required Elements**:
  - Review question (PICO/SPIDER)
  - Searches (databases, dates, restrictions)
  - Eligibility criteria
  - Data extraction plan
  - Risk of bias assessment method
  - Synthesis method
  - Dissemination plans

### Protocol Deviations
- **Document all changes**: Date, rationale, impact
- **Report in manuscript**: Transparent reporting of deviations
- **Avoid post-hoc changes**: Especially to eligibility criteria or outcomes

## Quality Indicators

### High-Quality Systematic Review Characteristics
‚úÖ Registered protocol (PROSPERO)
‚úÖ Comprehensive search (‚â•3 databases + grey literature)
‚úÖ Duplicate screening and extraction
‚úÖ Risk of bias assessment with validated tool
‚úÖ GRADE certainty assessment
‚úÖ Complete PRISMA reporting
‚úÖ Sensitivity analyses performed
‚úÖ Publication bias assessed (if ‚â•10 studies)
‚úÖ Conflicts of interest declared
‚úÖ Data sharing statement

### Red Flags
üö© No protocol or registration
üö© Single database searched
üö© Single reviewer for screening/extraction
üö© No risk of bias assessment
üö© Pooling highly heterogeneous studies without explanation
üö© Selective outcome reporting
üö© Industry funding without independent analysis

## Timeline Expectations

**Typical Systematic Review Timeline**:
- Protocol development: 2-4 weeks
- Search execution: 1-2 weeks
- Deduplication: 1-3 days
- Title/Abstract screening: 2-6 weeks (depends on n)
- Full-text review: 2-4 weeks
- Data extraction: 4-8 weeks
- Risk of bias assessment: 2-4 weeks
- Analysis: 2-4 weeks
- Manuscript writing: 4-8 weeks
- **Total**: 4-8 months (average 6 months)

**Factors Affecting Timeline**:
- Number of included studies (10 vs 100+)
- Complexity of interventions/outcomes
- Availability of full texts
- Need to contact authors
- Team size and availability

## Resources and Tools

### Essential Databases
- **PubMed/MEDLINE**: Biomedical literature (free)
- **Embase**: Broader coverage, especially European journals (subscription)
- **Cochrane CENTRAL**: Controlled trials (free)
- **Web of Science**: Citation tracking (subscription)
- **Scopus**: Multidisciplinary (subscription)
- **PsycINFO**: Psychology literature (subscription)

### Free Alternatives
- **Europe PMC**: Similar to PubMed with full-text access
- **Google Scholar**: Broad coverage but less precise
- **OpenAlex**: Open bibliographic database
- **Lens.org**: Patent and scholarly literature

### Grey Literature Sources
- **ClinicalTrials.gov**: Trial registry
- **WHO ICTRP**: International trial registry
- **ProQuest Dissertations**: Theses and dissertations
- **OpenGrey**: Grey literature in Europe
- **Conference proceedings**: Specialty society websites

### Reference Management
- **Zotero**: Free, open-source
- **Mendeley**: Free, cloud-based
- **EndNote**: Comprehensive (subscription)
- **Covidence**: Systematic review-specific (subscription)

### Screening and Extraction Tools
- **Rayyan**: Free web-based screening
- **Covidence**: End-to-end review management (subscription)
- **DistillerSR**: Advanced features (subscription)
- **EPPI-Reviewer**: Comprehensive (subscription)

### Statistical Analysis
- **RevMan**: Cochrane's free meta-analysis software
- **R (meta package)**: Flexible, powerful, free
- **Stata**: Comprehensive (subscription)
- **Comprehensive Meta-Analysis**: User-friendly (subscription)

## Citation Requirements

### Every Statement Must Be Traceable
‚úÖ **Correct**: "CBT reduces depression symptoms (SMD -0.42, 95% CI -0.58 to -0.26) [Source: PMID:12345678]"

‚ùå **Incorrect**: "CBT is effective for depression" (no citation, no effect size)

### Citation Format
- **Primary studies**: [Source: PMID:12345678] or [Source: DOI:10.1234/example]
- **Systematic reviews**: [Source: Cochrane:CD012345] or [Source: PMID:87654321]
- **Guidelines**: [Source: NICE NG222] or [Source: APA 2020]
- **Grey literature**: [Source: ClinicalTrials.gov NCT01234567]

### Confidence Thresholds
- **High confidence (0.9+)**: Multiple high-quality RCTs, consistent results
- **Moderate confidence (0.8-0.89)**: Some RCTs, minor inconsistency
- **Low confidence (0.6-0.79)**: Observational studies, significant heterogeneity
- **Very low confidence (<0.6)**: Single studies, high risk of bias

**Medical-grade threshold**: ‚â•0.8 confidence required for clinical recommendations

## Version Control
- **Version**: 1.0
- **Last Updated**: 2025-12-03
- **Maintained By**: MedResearch AI System
- **Review Cycle**: Quarterly updates to align with PRISMA, Cochrane, GRADE updates
